On Mar 2, 2022 Rondo Therapeutics closed a Series A round and raised $67,000,000 from Canaan Partners, Johnson & Johnson Innovation – JJDC, Novo Holdings, […]
Series B – NCX
On Mar 2, 2022 NCX closed a Series B round and raised $50,000,000 from Clearvision Ventures, Dalus Capital, Energize Ventures, IntercontinentalExchange, J.P. Morgan Asset Management, […]
Series B – Diality
On Mar 2, 2022 Diality closed a Series B round and raised $24,000,000 from investors, featuring lead investors . About the company: Diality is located […]
Series A – Vesalius Therapeutics
On Mar 2, 2022 Vesalius Therapeutics closed a Series A round and raised $75,000,000 from Flagship Pioneering, featuring lead investors Flagship Pioneering. About the company: […]
Post-IPO Debt – AptarGroup
On Mar 2, 2022 AptarGroup closed a Post-IPO Debt round and raised $400,000,000 from investors, featuring lead investors . About the company: AptarGroup is located […]
Post-IPO Debt – Verano Holdings
On Mar 2, 2022 Verano Holdings closed a Post-IPO Debt round and raised $100,000,000 from Advanced Flower Capital, featuring lead investors . About the company: […]
Post-IPO Debt – Bio-Rad Laboratories
On Mar 2, 2022 Bio-Rad Laboratories closed a Post-IPO Debt round and raised $1,200,000,000 from investors, featuring lead investors . About the company: Bio-Rad Laboratories […]
Series A – Rialtic
On Mar 2, 2022 Rialtic closed a Series A round and raised $28,000,000 from F-Prime Capital, Health Velocity Capital, Noro-Moseley Partners, Oak HC/FT, featuring lead […]
Series A – Alimetry
On Mar 2, 2022 Alimetry closed a Series A round and raised $16,300,000 from IP Group, K1W1, Matū Fund, Movac, Uniservices, featuring lead investors Movac. […]
LivWell Enlightened Health acquired by PharmaCann
Feb 28, 2022 PharmaCann has entered into an agreement to acquire LivWell Enlightened Health . PharmaCann based at Chicago, Illinois, United States. “PharmaCann is a […]
